Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of ceftazidime in bacterial otitis externa
IRCT20130427013136N6Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Apr 2020
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of ceftazidime in bacterial otitis externa, sponsored by Babol University of Medical Sciences. Started Apr 2020; status: completed.
02
Drugs
ceftazidime
03
Conditions
bacterial otitis externa
Beyond the preview
Go deeper on IRCT20130427013136N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130427013136N6.